PHAIRSON MEDICAL INC has a total of 47 patent applications. Its first patent ever was published in 1993. It filed its patents most often in Australia, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are INOUE KAZUTOMO, AVONTEC GMBH and IDERA PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 8 | |
#2 | EPO (European Patent Office) | 8 | |
#3 | WIPO (World Intellectual Property Organization) | 7 | |
#4 | United States | 5 | |
#5 | Canada | 4 | |
#6 | New Zealand | 3 | |
#7 | Brazil | 2 | |
#8 | Denmark | 1 | |
#9 | United Kingdom | 1 | |
#10 | Israel | 1 | |
#11 | Iceland | 1 | |
#12 | Japan | 1 | |
#13 | Mexico | 1 | |
#14 | Norway | 1 | |
#15 | Russian Federation | 1 | |
#16 | Sweden | 1 | |
#17 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Organic fine chemistry | |
#5 | Medical technology | |
#6 | Macromolecular chemistry and polymers | |
#7 | Measurement | |
#8 | Foods and drinks |
# | Name | Total Patents |
---|---|---|
#1 | Kay John | 21 |
#2 | Franklin Richard L | 17 |
#3 | Franklin Richard | 13 |
#4 | Hubbell Jeffrey A | 12 |
#5 | De Faire Johan | 10 |
#6 | Lindblom Ragnvald | 9 |
#7 | Cowling Didier S P | 8 |
#8 | Kille Peter | 7 |
#9 | Faire Johan De | 6 |
#10 | Cowling Didier | 5 |
Publication | Filing date | Title |
---|---|---|
WO0216443A1 | Novel polymer compounds | |
WO0215913A1 | Treatment of trauma, and other indications | |
AU2845400A | Treatment and prevention of immune rejection reactions | |
AU5207099A | Treatment of trauma | |
US6232088B1 | Treatment and prevention of immune rejection reactions | |
GB9828022D0 | Enzyme and DNA sequence encoding same | |
US6524814B1 | Enzyme and DNA sequence encoding krill-derived multifunctional protein | |
NZ503162A | Use of a krill- or atlantic cod-derived hydrolase with chymotrypsin, collagenase, elastase and/or exo peptidase activity to inactivate call adhesion components including ICAM-1 (CD54), CD4, CD8, CD11 and CD28. | |
US5958406A | Acne treatment with multifunctional enzyme | |
ZA9601030B | Multifunctional enzyme | |
US6030612A | Antimicrobial uses of multifunctional enzyme | |
US5945102A | Crustacean and fish derived multifunctional enzyme | |
WO9514489A1 | Composition comprising compounds for use as therapeutical agent |